CN103131037A - 一种天然高分子基止血敷料的制备 - Google Patents
一种天然高分子基止血敷料的制备 Download PDFInfo
- Publication number
- CN103131037A CN103131037A CN2013100312545A CN201310031254A CN103131037A CN 103131037 A CN103131037 A CN 103131037A CN 2013100312545 A CN2013100312545 A CN 2013100312545A CN 201310031254 A CN201310031254 A CN 201310031254A CN 103131037 A CN103131037 A CN 103131037A
- Authority
- CN
- China
- Prior art keywords
- solution
- composite polyelectrolyte
- liquid nitrogen
- polycation
- zymoplasm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920005615 natural polymer Polymers 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 15
- 230000023597 hemostasis Effects 0.000 title abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 68
- 229920000867 polyelectrolyte Polymers 0.000 claims abstract description 62
- 239000002131 composite material Substances 0.000 claims abstract description 59
- 239000000835 fiber Substances 0.000 claims abstract description 36
- 239000007788 liquid Substances 0.000 claims abstract description 36
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 34
- 229920000447 polyanionic polymer Polymers 0.000 claims abstract description 13
- 229920001661 Chitosan Polymers 0.000 claims description 41
- 238000007710 freezing Methods 0.000 claims description 36
- 230000008014 freezing Effects 0.000 claims description 36
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 32
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 18
- 229920002674 hyaluronan Polymers 0.000 claims description 18
- 235000010413 sodium alginate Nutrition 0.000 claims description 18
- 229940005550 sodium alginate Drugs 0.000 claims description 18
- 239000000661 sodium alginate Substances 0.000 claims description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 17
- 229960003160 hyaluronic acid Drugs 0.000 claims description 17
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 16
- 229910021641 deionized water Inorganic materials 0.000 claims description 16
- 235000019253 formic acid Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 6
- 230000029663 wound healing Effects 0.000 abstract description 4
- 108090000190 Thrombin Proteins 0.000 abstract 4
- 229960004072 thrombin Drugs 0.000 abstract 4
- 238000005057 refrigeration Methods 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 14
- 229920002101 Chitin Polymers 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 230000001413 cellular effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000000025 haemostatic effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940045110 chitosan Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031254.5A CN103131037B (zh) | 2013-01-28 | 2013-01-28 | 一种天然高分子基止血敷料的制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031254.5A CN103131037B (zh) | 2013-01-28 | 2013-01-28 | 一种天然高分子基止血敷料的制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103131037A true CN103131037A (zh) | 2013-06-05 |
CN103131037B CN103131037B (zh) | 2014-10-01 |
Family
ID=48491528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310031254.5A Active CN103131037B (zh) | 2013-01-28 | 2013-01-28 | 一种天然高分子基止血敷料的制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103131037B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104497345A (zh) * | 2015-01-06 | 2015-04-08 | 王健 | 一种透明质酸-壳聚糖可降解敷料的制备方法 |
CN104784741A (zh) * | 2015-04-23 | 2015-07-22 | 武汉市思泰利医疗器械发展有限公司 | 壳聚糖功能性水胶体医用敷料 |
CN107041965A (zh) * | 2016-12-26 | 2017-08-15 | 广东海洋大学 | 一种高效止血海绵及其制备方法 |
CN107412842A (zh) * | 2017-04-28 | 2017-12-01 | 广东泰宝医疗科技股份有限公司 | 一种带凝血酶的海藻酸盐伤口敷贴的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1509768A (zh) * | 2002-12-20 | 2004-07-07 | 止血创伤敷料和织物及它们的制造和使用方法 | |
CN102383267A (zh) * | 2011-07-22 | 2012-03-21 | 北京化工大学 | 冻干法制备天然高分子基纳米纤维膜 |
-
2013
- 2013-01-28 CN CN201310031254.5A patent/CN103131037B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1509768A (zh) * | 2002-12-20 | 2004-07-07 | 止血创伤敷料和织物及它们的制造和使用方法 | |
CN102383267A (zh) * | 2011-07-22 | 2012-03-21 | 北京化工大学 | 冻干法制备天然高分子基纳米纤维膜 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104497345A (zh) * | 2015-01-06 | 2015-04-08 | 王健 | 一种透明质酸-壳聚糖可降解敷料的制备方法 |
CN104784741A (zh) * | 2015-04-23 | 2015-07-22 | 武汉市思泰利医疗器械发展有限公司 | 壳聚糖功能性水胶体医用敷料 |
CN107041965A (zh) * | 2016-12-26 | 2017-08-15 | 广东海洋大学 | 一种高效止血海绵及其制备方法 |
CN107412842A (zh) * | 2017-04-28 | 2017-12-01 | 广东泰宝医疗科技股份有限公司 | 一种带凝血酶的海藻酸盐伤口敷贴的制备方法 |
CN107412842B (zh) * | 2017-04-28 | 2020-05-05 | 广东泰宝医疗科技股份有限公司 | 一种带凝血酶的海藻酸盐伤口敷贴的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103131037B (zh) | 2014-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108904875B (zh) | 一种促进慢性创面愈合的抗菌自愈合水凝胶辅料及其制备方法和应用 | |
CN103446621B (zh) | 一种含纳米银的海藻酸钠基抗菌医用敷料的制备方法 | |
Zhang et al. | Application status and technical analysis of chitosan-based medical dressings: A review | |
Lin et al. | Preparation and properties of carboxymethyl chitosan/oxidized hydroxyethyl cellulose hydrogel | |
CN103736134B (zh) | 一种医用海绵敷料及其制备方法 | |
CN103131037B (zh) | 一种天然高分子基止血敷料的制备 | |
CN106474523A (zh) | 基于羧甲基壳聚糖的聚电解质海绵创伤敷料的制备方法 | |
CN106474530A (zh) | 一种基于壳寡糖的聚电解质海绵止血敷料的制备方法 | |
CN102908653A (zh) | 一种用于深度感染性伤口的抗菌敷料制备方法 | |
Zhao et al. | Chitosan-based hydrogel wound dressing: From mechanism to applications, a review | |
Zhang et al. | Diversified antibacterial modification and latest applications of polysaccharide-based hydrogels for wound healthcare | |
CN101284145A (zh) | 一种医用敷料及其制备方法和用途 | |
CN103463667A (zh) | 一种纳米银海藻酸钙抗菌医用敷料的制备方法 | |
CN105079863A (zh) | 一种芦荟/海藻酸钠双层水凝胶敷料的制备方法 | |
CN107261200B (zh) | 一种壳聚糖-纳米锂藻土复合凝胶伤口敷料及其制备方法 | |
CN109731121A (zh) | 一种含有介孔二氧化硅的纤维素和壳聚糖复合敷料的制备方法 | |
Chen et al. | A quaternized chitosan and carboxylated cellulose nanofiber-based sponge with a microchannel structure for rapid hemostasis and wound healing | |
CN114031807B (zh) | 一种用于组织创伤愈合修复的纤维素壳聚糖单宁酸铜复合凝胶海绵及其制备方法 | |
CN106110383A (zh) | 一种壳聚糖藻酸盐敷料及其冻干制备方法 | |
Hasan et al. | Biopolymers in diabetic wound care management: A potential substitute to traditional dressings | |
CN114000349A (zh) | 海藻酸盐封装细菌纤维素复合光热抗菌医用敷料及制备方法 | |
CN114225088A (zh) | 一种复合多层敷料及其制备方法和应用 | |
Li et al. | Construction of porous structure-based carboxymethyl chitosan/sodium alginate/tea polyphenols for wound dressing | |
CN106110367A (zh) | 基于天然高分子多层复合医用敷料及其制备方法 | |
Wang et al. | Antibacterial, anti-inflammatory, rapid hemostasis, and accelerated repair by multifunctional metal–organic frameworks fibrous scaffolds for diabetic wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180910 Address after: 225321 8 Yuandong Avenue, Taizhou Port Industrial Park, Jiangsu Patentee after: ROOSIN MEDICAL CO., LTD. Address before: 213164 A Block A211, Changzhou Advanced Materials Research Institute, Beijing University of Chemical Technology, 520 Avenue, 801 Changwu Middle Road, Changzhou City, Jiangsu Province Patentee before: Changzhou Institute of Advanced Material, Beijing University of Chemical Technology |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of a natural polymer based hemostatic dressing Effective date of registration: 20201215 Granted publication date: 20141001 Pledgee: Bank of China Limited by Share Ltd. Taizhou Gaogang sub branch Pledgor: TAIZHOU ROOSIN MEDICAL PRODUCT Co.,Ltd. Registration number: Y2020980009396 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211228 Granted publication date: 20141001 Pledgee: Bank of China Limited by Share Ltd. Taizhou Gaogang sub branch Pledgor: TAIZHOU ROOSIN MEDICAL PRODUCT CO.,LTD. Registration number: Y2020980009396 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of a natural polymer based hemostatic dressing Effective date of registration: 20211229 Granted publication date: 20141001 Pledgee: Bank of China Limited by Share Ltd. Taizhou Gaogang sub branch Pledgor: TAIZHOU ROOSIN MEDICAL PRODUCT CO.,LTD. Registration number: Y2021980016869 |